scispace - formally typeset
M

Masashi Mizokami

Researcher at Nagoya City University

Publications -  684
Citations -  37168

Masashi Mizokami is an academic researcher from Nagoya City University. The author has contributed to research in topics: Hepatitis B virus & Hepatitis C virus. The author has an hindex of 85, co-authored 650 publications receiving 34868 citations. Previous affiliations of Masashi Mizokami include National Institute of Advanced Industrial Science and Technology & University of Florida.

Papers
More filters
Journal ArticleDOI

Spread times of hepatitis C virus estimated by the molecular clock differ among Japan, the United States and Egypt in reflection of their distinct socioeconomic backgrounds.

TL;DR: Infection with hepatitis C virus (HCV) is taking an ever increasing role in the development of hepatocellular carcinoma (HCC) over the world as discussed by the authors.
Journal ArticleDOI

Classifying genotype F of hepatitis B virus into F1 and F2 subtypes.

TL;DR: Classifying HBV/F isolates into two subtypes (F1 and F2) would be more appropriate than providing them with two distinct genotypes (F and H).
Journal ArticleDOI

Molecular dissection of HBV evasion from restriction factor tetherin: A new perspective for antiviral cell therapy

TL;DR: It is demonstrated that HBV surface protein (HBs) plays a crucial role in counteracting the IFN-induced antiviral response mediated by tetherin (also known as BST-2), and strategies to augment the antiviral activity of tetherin by impeding tetherin-HBs interactions may be viable as a therapeutic intervention against HBV.
Journal ArticleDOI

Pyogenic granuloma of the stomach successfully treated by endoscopic resection after transarterial embolization of the feeding artery

TL;DR: An 82-year-old man admitted to hospital because of melena of more than 3 months, duration, was diagnosed as a pyogenic granuloma arising from the gastric mucosa and there was no evidence of tumor recurrence on follow-up EGD.
Journal ArticleDOI

Cellular and humoral immune reactions against autoantigens and hepatitis C viral antigens in chronic hepatitis C

TL;DR: Specific immunocompetence against HCV-related antigens can often be shown in patients with chronic hepatitis C but is infrequently accompanied by autoreactions against liver-specific or nonspecific antIGens.